Related references
Note: Only part of the references are listed.Bone markers and cardiovascular risk in type 2 diabetes patients
Sabine R. Zwakenberg et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Circulating levels of sclerostin are associated with cardiovascular mortality
Cristina Novo-Rodriguez et al.
PLOS ONE (2018)
The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans
Giuseppe Daniele et al.
ACTA DIABETOLOGICA (2018)
Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
Peng Duan et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)
Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects
Sergio Sanchez-Enriquez et al.
WORLD JOURNAL OF DIABETES (2017)
Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile
I. Barchetta et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
New insights into the biology of osteocalcin
Meredith L. Zoch et al.
BONE (2016)
Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Rena M. Pollack et al.
DIABETES CARE (2016)
Carotid Plaque Calcification Predicts Future Cardiovascular Events in Type 2 Diabetes
Saula Vigili de Kreutzenberg et al.
DIABETES CARE (2015)
Glucose stimulates chondrocyte differentiation of vascular smooth muscle cells and calcification: A possible role for IL-1β
Laurence Bessueille et al.
FEBS LETTERS (2015)
Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease
Taichirou Morisawa et al.
INTERNATIONAL HEART JOURNAL (2015)
Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women
Joshua R. Lewis et al.
PLOS ONE (2015)
Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6
Andrea Callegari et al.
JOURNAL OF VASCULAR RESEARCH (2014)
Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease
A. E. Berezin et al.
ATHEROSCLEROSIS (2013)
Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
Sonia Morales-Santana et al.
DIABETES CARE (2013)
Serum osteoprotegerin: Bone or cardiovascular marker in Type 2 diabetes males?
P. Rozas Moreno et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2013)
Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function
Dhruv K. Singh et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
Mikael K. Poulsen et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
F. W. Kiefer et al.
DIABETOLOGIA (2011)
The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM
Chan-Hee Jung et al.
ACTA DIABETOLOGICA (2010)
Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus
Xiaoxiang Yan et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice
Justin Chapman et al.
PLOS ONE (2010)
RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4-Dependent Pathway
Sara Panizo et al.
CIRCULATION RESEARCH (2009)
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice
Sean Morony et al.
CIRCULATION (2008)
Determinants of progression of coronary artery calcification in type 2 diabetes
Dhakshinamurthy Vijay Anand et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects
DV Anand et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
CP Wilkinson et al.
OPHTHALMOLOGY (2003)
Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications
ST Knudsen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Share Paper
